drugset / Trial / NCT06749470

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study on the Treatment of Depression with Jieyu Chufan Capsules

NCT06749470 ↗

Phase 4 Not yet recruiting 480 enrolled Central South University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy of Jieyu Chufan Capsules, with placebo as the control, in combination with SSRIs in patients with moderate and severe depression. To observe the safety of Jieyu Chufan Capsules and its effects in improving the side effects of SSRIs.

Timeline

Start
2024-12-22
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Jieyu Chufan Capsules Unknown 0.4 g —